MedPage Today on MSN
Oral Drug Wins FDA Approval for Chronic Hives
The FDA approved oral remibrutinib (Rhapsido) as a second-line treatment for chronic spontaneous urticaria (CSU), or chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback